WednesdayApr 06, 2022 3:09 pm

How You Can Participate in a Psychedelic Clinical Trial

These last few years, clinical trials on the use of psychedelics such as MDMA, LSD or psilocybin as treatments for various mental health conditions have increased significantly. For clinical trials to run, however, participants are needed. At first glance, it may seem easy to enroll individuals for trials given that quite a number of people suffer from mental conditions such as depression and anxiety. However, for an individual to be enrolled into a clinical trial, they must meet the stipulated inclusion criteria in order to be eligible. Below are steps on how one can enroll in a psychedelic clinical trial.…

Continue Reading

TuesdayApr 05, 2022 3:29 pm

Ibogaine Blocks Reward Pathways in Alcohol-Dependent Mice

New research has found that ibogaine blocks some of the abuse-related effects of alcohol in mice. Ibogaine is a natural product extracted from the Tabernanthe iboga plant. It is commonly used during religious ceremonies in the form of tea and is extracted from the plant’s root, bark and stem. Alcohol use disorder is a chronic illness that is characterized by uncontrollable drinking. Symptoms include the repeated consumption of alcohol despite related health and legal problems. This disorder is a leading cause of death and absenteeism globally and is recognized as a global public health issue. However, the current treatments used…

Continue Reading

TuesdayApr 05, 2022 9:00 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Begins Recruitment for Study Measuring Ketamine’s Psychedelic Effect

Cybin-sponsored study will use Kernel Flow, Kernel’s quantitative neuroimaging. Company hopes to learn more about impact ketamine has on brain activity, overall mental well-being. Study results may lead to future studies supporting CYBN’s mission to develop psychedelics into therapeutics. Cybin’s (NEO: CYBN) (NYSE American: CYBN) efforts to transform the mental-health treatment landscape have reached a key milestone: the company is actively recruiting participants for its upcoming feasibility study using Kernel Flow, Kernel’s quantitative neuroimaging technology (https://ibn.fm/9aSxc). “The feasibility study using Kernel Flow offers an opportunity for researchers and our study participants to quantifiably gather information on a psychedelic experience,” said Cybin…

Continue Reading

TuesdayApr 05, 2022 9:00 am

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Leveraging Growth Across Multiple Markets Including Mental Health, Healthcare IT

Mydecine was founded in 2020 as a response to the lack of innovation addressing mental health treatment and the therapeutic possibilities represented by psychedelic compounds and other novel molecules The world is experiencing a shortage of mental health resources, while faced with an increase in mental health issues on the heels of the pandemic Mydecine is leveraging the psychedelic drugs market, the PTSD market, and healthcare IT markets – with potential growth across all avenues In the first year of the COVID-19 pandemic, the prevalence of anxiety and depression worldwide increased by 25%, according to a World Health Organization (“WHO”)…

Continue Reading

MondayApr 04, 2022 1:46 pm

Activists in Michigan Start Signature Collection Efforts for Psychedelic Legalization Ballot Measure

Earlier this week, activists in the state of Michigan began a signature drive to collect signatures to place an initiative to legalize the sharing, possession and cultivation of psychedelics on the coming statewide ballot. Students for Sensible Drug Policy, a youth-led organization, and the Decriminalize Nature chapter in Michigan are collaborating in this effort. The measure would establish a system for the spiritual and therapeutic use of psychedelic substances. The legislation also permits counseling, spiritual, harm reduction, therapeutic, guidance, supervision and associated supportive services. The initiative also authorizes entities that have acquired a certificate of need from the state’s Department…

Continue Reading

MondayApr 04, 2022 9:15 am

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) CEO to Present at Three Upcoming Investor Conferences Spotlighting the Company’s Strategic Outlook for the Remainder of 2022

Delic Holdings Co-founder and CEO, Matt Stang, will take part in three upcoming conferences – the Scottdale Capital Event, the Planet MicroCap Showcase, and the H.C. Wainwright Annual Global Life Sciences Conference In presentations and one-on-one meetings, Stang will discuss Delic’s new revenue lines and strategic outlook for the remainder of the year During a recent interview on The Jesse Tee Show, Stang noted the company intends to scale its ketamine clinics as well as build infrastructure to accommodate expanded psychedelic healing  The company hopes to utilize its expanded infrastructure to help destigmatize mental health conditions  Delic Holdings (CSE: DELC)…

Continue Reading

FridayApr 01, 2022 3:03 pm

Psychedelics May Boost Connectedness with Nature

A new study has looked into how therapeutic psychedelic administration combined with the calm properties of nature-based settings has the capacity to improve an individual’s mental well-being as well as bolster their relationship with nature. The study was conducted by a team of researchers from the Center for Psychedelic Research at Imperial College in London. Its findings were reported in “Health Psychology.” Contact with nature and the therapeutic administration of psychedelics has been linked to similar psychological mechanisms, including amplified states of transcendent experiences and awe, increased psychological connectedness and reduced rumination, which are all processes associated with improvements in…

Continue Reading

ThursdayMar 31, 2022 3:40 pm

Four Psychedelics Movies to Watch

Interest in psychedelic substances has grown significantly these last couple of years as studies unearth more evidence on their benefits and numerous uses. That interest isn’t just confined to uses and benefits; attention has also been paid to psychedelic media. If you’re interested in consuming psychedelic media but aren’t sure where to look, you can start here. Below are a few psychedelic movies that you can watch. “Spirited Away” This animated feature was directed and written by Hayao Miyazaki and animated by Studio Ghibli. It conveys the story of a young girl who enters the world of spirits while she…

Continue Reading

WednesdayMar 30, 2022 2:12 pm

New Research Finds That Psilocybin May Help Decrease Weight Gain

Results from a recently conducted animal study show that psilocybin may be effective in decreasing weight gain in obese subjects. Psilocybin is the psychoactive compound found in hallucinogenic mushrooms. Based on prior findings, researchers believe that the compound could be useful in the treatment of various mental health indications, especially when administered in conjunction with therapy. This particular study was carried out by NeonMind Biosciences, an integrated psychedelic drug development and wellness firm. The firm had in the recent past concluded similar research, which found that the psychedelic decreased weight gain in healthy animal subjects. The psychedelic drug company used…

Continue Reading

WednesdayMar 30, 2022 9:00 am

Silo Pharma Inc. (SILO) Is ‘One to Watch’

Silo recently extended its option with the University of Maryland, Baltimore to explore arthritogenic joint-homing peptides and their use in arthritis-inflamed joints In December 2021, the company announced the issuance of a patent relating to its University of Maryland, Baltimore licensed homing peptide for enhanced targeting of therapeutic agents to the central nervous system The company signed an agreement with Columbia University granting it an option to license certain assets currently under development, including an Alzheimer’s disease formulation targeting NDMARs and 5-HT4Rs, as well as a prophylactic treatment for stress-induced disorders and PTSD Silo currently has under review four U.S.…

Continue Reading

PsychedelicNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 415.949.5050